Fig. 3
From: Landscape of tumor suppressor long noncoding RNAs in breast cancer
TSLNR expression correlated with favorable overall survival in the pancancer cohort. (a-l) The patients with high expression (N = 5091) of TSLNRs (EPB41L4A-AS2 (a), WEE2-AS1 (b), ACVR2B-AS1 (c), PGM5-AS1 (d), LINC00667 (e), CYP1B1-AS1 (f), FAM66C (g), FTX (h), SNHG5 (i), HCG11 (j), WWC2-AS2 (k) and TRHDE-AS1 (l)) had more favorable overall survival than those with low expression (N = 5091) in the pancancer cohort